FDA Approves Soolantra for Rosacea
It was recently announced that the FDA is approving Soolantra as a treatment for rosacea. What makes Soolantra different than the other topical medications that are currently on the market? Read on to learn everything you need to know.
Soolantra is a new rosacea medication created by Galderma. Galderma’s been creating medical solutions since 1981 and specialize in dermatological conditions like acne, psoriasis, and rosacea. They’re also the makers of Cetaphil, a popular mild skin car product used by people with rosacea.
To gain approval, Soolantra underwent two tests, each lasting three months. The 910 rosacea patients involved in the study saw fewer pustules and less redness as early as two weeks after the first application. After a full year of use, the cream had few side effects, skin irritation and a burning sensation being the one reported by a few of the participants.
Why Soolantra Works
Soolantra is not an antibacterial remedy as many rosacea treatments are. Instead, Soolantra goes with the thought and studies that find Demodex mites may be to blame for the redness and inflammation that is the leading symptom of this skin condition. Soolantra’s main ingredient is ivermectin, an anti-parasitic medication used commonly to prevent and treat parasitic worms, such as roundworms, and other parasites like mites. In fact, if you own horses or cattle, you likely make oral ivermectin doses a party of regular care. In addition, ivermectin offers anti-inflammatory properties.
Using Soolantra couldn’t be easier. You apply a pea-sized amount to your face once a day.
Benefits to Soolantra
In addition to potentially killing the mites that are believed to be linked to rosacea, Soolantra is also a fragrance-free and gentle moisturizer. Soolantra blends the one-percent ivermectin into Cetaphil’s moisturizer. You gain the benefits of reducing redness and inflammation and also preventing dry skin.